Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile
General Stock Board Listed Company Profile
Code:
Industry:
Local/Foreign Company:
6589 EirGenix
中文
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
Chung-Hur Lee Lee-Cheng Liu Lee-Cheng Liu (02)7708-0123 No.101, Lane 169, Kangning St., Xizhi Dist.New Taipei City 22180, Taiwan (R.O.C.) 2019/06/28
Industry Main Business
Biotechnology and Medical Care
EirGenix operates two business units, a CDMO unit providing biopharmaceutical contract development and manufacturing services and a product unit developing high quality and affordable biosimilars to the benefits of patients around the global. EirGenix owned 2 cGMP facilities (one mammalian, one microbial) in New Taipei City. Another commercial production facility with the scale of twelve 12 2000 L single use bioreactor systems in Zhubei, Northern Taiwan. EirGenix is committed to providing client-centric products and services to ensure our customers achieve their business goals.Our dedicated team of professionals work closely with our clients to ensure that our clients receive the highest-quality products and services that are both timely and cost-effective. By striving to be a responsible and reliable service provider, we hope to build lasting and mutually-productive partnerships with our clients.
 
Market Information ( 2019/11/19 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
margin
balance
(1,000shr.)
Short
margin
balance
(1,000shr.)
272.021 28.30  27.95  28.20  -0.30  119 0.16 N/A N/A
Trading method Fun
purchase
price or
securities
pneeded
on T day
Announcement of Irregularity
(2019/11/20)
TPEx measures
adopted
(2019/11/20)
With warrants Can be shorted or margined? Detail
Normal N N N N N Today History
 
Financial Reports
Cash Flows Items
Amount
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Balance
Sheets
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Profit
Other comprehensive income
Comprehensive income
Basic earnings per share
* Auditor's report on latest financial statements: auditor's report:
* More detail:MOPS
* Foreign issuers’ information is disclosed in consolidated statements.